Searched for
GLENMARK PHARMA PROFIT
Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...- Glenmark Pharma shares in focus as Q1 profit slumps 86% YoYGlenmark Pharma reported an 86% YoY drop in Q1FY26 net profit to Rs 46.9 crore, even as revenue stayed flat at Rs 3,264 crore. EBITDA slipp...
- Stocks in news: Vodafone Idea, Coal India, Glenmark Pharma, Inox Wind, IIFL FinanceMarkets remained mostly unchanged on the weekly expiry day. Vodafone Idea's net losses widened, while Coal India advances its infrastructur...
- Stocks in news: DMart, IREDA, TCS, ZEE, HUL, Glenmark PharmaMarkets declined on weekly expiry day, with several companies in focus due to earnings and news. TCS reported a 6% profit increase, while I...
- Glenmark Pharma shares in focus as company swings back to profit in Q3Glenmark Pharmaceuticals reported a net profit of Rs 348 crore for Q3FY25, a significant turnaround from a Rs 351 crore loss in the previou...
- Stocks in news: Ola Electric, Hindustan Zinc, SpiceJet, SBI, Glenmark PharmaStocks in news: The domestic markets closed flat on Wednesday. Hindustan Zinc set a floor price of Rs 486 for its offer for sale. SpiceJet’...
- Glenmark Life Sciences Q2 Results: Firm posts profit rise on API boostHowever, a nearly 18% rise in expenses ate into the company's core profit margin, which contracted to 29% from 30.2% a year earlier.
- Glenmark closes 3% lower post API arm sale dealAccording to analysts, the sale of Glenmark Life could impact the profitability of Glenmark Pharma in FY25 but lower interest payments coul...
- Glenmark Pharma Q4 Results: Profit declines 12.3% on higher input costs and lower demandGlenmark Pharmaceuticals' Q4 consolidated profit before exceptional items and tax was INR3.09bn ($37.78m) for the quarter ended 31 March, d...
- Glenmark Life Sciences Q3 Results: Profit rises 1% on API strengthGlenmark Life Sciences, which was spun off from Glenmark Pharmaceuticals in 2019 to focus on the API business, posted revenue from operatio...
- Buy Glenmark Pharmaceuticals, target price Rs 440: ICICI DirectGlenmark Pharmaceuticals Ltd., incorporated in the year 1977, is a Mid Cap company (having a market cap of Rs 11089.21 Crore) operating in ...
- Glenmark Pharma reports 31% drop in net profit to Rs 211 croreGlenmark is ranked 14th with a market share of 2.17% Sales from North America fell 10.2% YoY to Rs 663 crore. Europe sales saw 8% YoY to Rs...
- Glenmark soars over 21% on CLSA’s upgradeThe stock has fallen over 42 per cent in the last one year.
- Glenmark falls as CS downgrades stock to 'Neutral' ahead of Q1 numbersCredit Suisse believes that the pharma stock is already pricing in the best case scenario, which includes sustenance of profitability from ...
- Rouble fallout: Dr Reddy's, Ranbaxy's profit in troubleDepreciation of the Russian currency poses a risk to the profitability of Indian pharma companies such as Dr Reddy's, Glenmark and Ranbaxy.
- Glenmark Pharma hits 52-week high, analysts recommend ‘buy’The company company had posted a net profit of Rs 208.58 crore during the same period of the previous fiscal, Glenmark Pharmaceuticals said...
- Hold Glenmark Pharma for profits: Shardul KulkarniThis stock has achieved its price target. From a trading perspective, one should book profits.
- Book profits in Piramal at 137-138: APTART Technical Advisory ServicesSandeep Wagle, founder & MD, APTART Technical Advisory Services, in a chat with ET Now talks about Piramal Life Sciences and Glenmark Pharm...
- Buy Glenmark for target Rs 608: EmkayEmkay Share and Stock Brokers has initiated coverage on Glenmark Pharma with a ‘buy’ rating for a target price of Rs 608, an upside of 35 p...
- Glenmark to make Europe foray with Rs 100 cr buyLeading mid-sized pharma company Glenmark Pharmaceuticals will soon enter the European market by acquiring a front-end pharmaceutical compa...
Load More
